Pheochromocytomas/paragangliomas are characterized by a unique molecular landscape
that allows their assignment to clusters based on underlying genetic alterations. With around …

An adrenal incidentaloma is now established as a common endocrine diagnosis that
requires a multidisciplinary approach for effective management. The majority of patients can …

A molecular biology–based taxonomy has been proposed for pheochromocytoma and
paraganglioma (PPGL). Data from the Cancer Genome Atlas revealed clinically relevant …

Pheochromocytomas and paragangliomas (PCC/PGLs) are rare, mostly catecholamine-
producing neuroendocrine tumors of the adrenal gland (PCCs) or the extra-adrenal …

Objective: Our objective was to evaluate the published literature and reach a consensus on
the treatment of patients with ACTH-dependent Cushing's syndrome, because there is no …

Context: Pheochromocytomas and paragangliomas (PHEO/PGL) are neuroendocrine
tumors that arise from sympathetic and parasympathetic paraganglia. Diagnosed rarely …

In the last decades, minimally invasive transperitoneal laparoscopic adrenalectomy has
become the standard of care for surgical resection of the adrenal gland tumors. Recently …

Background. Mortality associated with surgery for phaeochromocytoma has dramatically
decreased over the last decades. Many factors contributed to the dramatic decline of the …

BACKGROUND: Pheochromocytomas vary in presentation, tumor size, and in
catecholamine production. Whether pheochromocytoma size correlates with hormone …

This article aims to review current concepts in diagnosing and managing
pheochromocytoma and paraganglioma (PPGL). Personalized genetic testing is vital, as 40 …